Balchem (NASDAQ:BCPC) Announces Quarterly Earnings Results

Balchem (NASDAQ:BCPC) announced its earnings results on Friday. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.11 by ($0.08), Zacks reports. Balchem had a net margin of 12.90% and a return on equity of 10.99%.

Balchem Stock Up 1.5 %

Balchem stock opened at $163.72 on Friday. The stock has a market capitalization of $5.32 billion, a price-to-earnings ratio of 44.01, a PEG ratio of 4.41 and a beta of 0.69. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90. The business has a fifty day moving average price of $162.20 and a 200-day moving average price of $169.32. Balchem has a 1-year low of $137.69 and a 1-year high of $186.03.

Balchem Increases Dividend

The firm also recently disclosed an annual dividend, which was paid on Friday, January 17th. Stockholders of record on Thursday, December 26th were given a $0.87 dividend. This is a boost from Balchem’s previous annual dividend of $0.79. The ex-dividend date was Thursday, December 26th. This represents a dividend yield of 0.4%. Balchem’s dividend payout ratio (DPR) is presently 23.39%.

Wall Street Analysts Forecast Growth

BCPC has been the topic of several recent research reports. HC Wainwright increased their target price on Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a research report on Monday, November 4th. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.